Literature DB >> 20624454

Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program.

P Aeby1, T Ashikaga, S Bessou-Touya, A Schepky, F Gerberick, P Kern, M Marrec-Fairley, G Maxwell, J-M Ovigne, H Sakaguchi, K Reisinger, M Tailhardat, S Martinozzi-Teissier, P Winkler.   

Abstract

The sensitizing potential of chemicals is usually identified and characterized using one of the available animal test methods, such as the mouse local lymph node assay. Due to the increasing public and political concerns regarding the use of animals for the screening of new chemicals, the Colipa Skin Tolerance Task Force collaborates with and/or funds research groups to increase and apply our understanding of the events occurring during the acquisition of skin sensitization. Knowledge gained from this research is used to support the development and evaluation of novel alternative approaches for the identification and characterization of skin sensitizing chemicals. At present one in chemico (direct peptide reactivity assay (DPRA)) and two in vitro test methods (cell based assays (MUSST and h-CLAT)) have been evaluated within Colipa inter-laboratory ring trials and accepted by the European Centre for the Validation of Alternative Methods (ECVAM) for pre-validation. Data from all three test methods will be used to support the development of testing strategy approaches for skin sensitizer potency prediction. The replacement of the need for animal testing for skin sensitization risk assessment is viewed as ultimately achievable and the next couple of years should set the timeline for this milestone. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624454     DOI: 10.1016/j.tiv.2010.07.005

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds.

Authors:  Vinicius M Alves; Eugene Muratov; Denis Fourches; Judy Strickland; Nicole Kleinstreuer; Carolina H Andrade; Alexander Tropsha
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-03       Impact factor: 4.219

2.  Pyridoxylamine reactivity kinetics as an amine based nucleophile for screening electrophilic dermal sensitizers.

Authors:  Itai Chipinda; Wilbes Mbiya; Risikat Ajibola Adigun; Moshood K Morakinyo; Brandon F Law; Reuben H Simoyi; Paul D Siegel
Journal:  Toxicology       Date:  2013-12-12       Impact factor: 4.221

3.  Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis.

Authors:  Nripen S Sharma; Rohit Jindal; Bhaskar Mitra; Serom Lee; Lulu Li; Tim J Maguire; Rene Schloss; Martin L Yarmush
Journal:  Cell Mol Bioeng       Date:  2012-03       Impact factor: 2.321

4.  The LLNA: A Brief Review of Recent Advances and Limitations.

Authors:  Stacey E Anderson; Paul D Siegel; B J Meade
Journal:  J Allergy (Cairo)       Date:  2011-06-16

Review 5.  In vitro methods for hazard assessment of industrial chemicals - opportunities and challenges.

Authors:  Chin Lin Wong; Sussan Ghassabian; Maree T Smith; Ai-Leen Lam
Journal:  Front Pharmacol       Date:  2015-05-05       Impact factor: 5.810

Review 6.  GINIplus and LISAplus - Design and selected results of two German birth cohorts about natural course of atopic diseases and their determinants.

Authors:  J Heinrich; I Brüske; C Cramer; U Hoffmann; M Schnappinger; B Schaaf; A von Berg; D Berdel; U Krämer; I Lehmann; O Herbarth; M Borte; A Grübl; C P Bauer; C Beckmann; H Behrendt; J Ring; S Koletzko
Journal:  Allergol Select       Date:  2017-08-04

7.  Determination of Protein Haptenation by Chemical Sensitizers Within the Complexity of the Human Skin Proteome.

Authors:  Erika Parkinson; Maja Aleksic; Richard Cubberley; Gushinder Kaur-Atwal; Johannes P C Vissers; Paul Skipp
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.